FURACIN Drug Patent Profile
✉ Email this page to a colleague
When do Furacin patents expire, and what generic alternatives are available?
Furacin is a drug marketed by Shire and is included in three NDAs.
The generic ingredient in FURACIN is nitrofurazone. There are four drug master file entries for this compound. Additional details are available on the nitrofurazone profile page.
Summary for FURACIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 2,803 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FURACIN at DailyMed |
US Patents and Regulatory Information for FURACIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shire | FURACIN | nitrofurazone | CREAM;TOPICAL | 083789-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shire | FURACIN | nitrofurazone | OINTMENT;TOPICAL | 005795-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shire | FURACIN | nitrofurazone | POWDER;TOPICAL | 083791-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |